S&P 500   3,984.88 (+0.84%)
DOW   32,417.81 (+0.54%)
QQQ   308.35 (+0.78%)
AAPL   158.58 (+0.75%)
MSFT   272.72 (+0.18%)
META   200.08 (+1.15%)
GOOGL   104.55 (+3.29%)
AMZN   99.52 (+1.85%)
TSLA   196.10 (+7.01%)
NVDA   259.30 (+0.12%)
NIO   9.23 (+5.49%)
BABA   83.37 (+2.93%)
AMD   95.11 (-1.76%)
T   18.46 (-0.16%)
F   11.75 (+5.10%)
MU   58.26 (+1.08%)
CGC   1.98 (+6.45%)
GE   92.54 (+2.91%)
DIS   96.25 (+2.15%)
AMC   4.40 (+3.04%)
PFE   40.42 (-0.96%)
PYPL   75.84 (+3.59%)
NFLX   305.24 (+0.04%)
S&P 500   3,984.88 (+0.84%)
DOW   32,417.81 (+0.54%)
QQQ   308.35 (+0.78%)
AAPL   158.58 (+0.75%)
MSFT   272.72 (+0.18%)
META   200.08 (+1.15%)
GOOGL   104.55 (+3.29%)
AMZN   99.52 (+1.85%)
TSLA   196.10 (+7.01%)
NVDA   259.30 (+0.12%)
NIO   9.23 (+5.49%)
BABA   83.37 (+2.93%)
AMD   95.11 (-1.76%)
T   18.46 (-0.16%)
F   11.75 (+5.10%)
MU   58.26 (+1.08%)
CGC   1.98 (+6.45%)
GE   92.54 (+2.91%)
DIS   96.25 (+2.15%)
AMC   4.40 (+3.04%)
PFE   40.42 (-0.96%)
PYPL   75.84 (+3.59%)
NFLX   305.24 (+0.04%)
S&P 500   3,984.88 (+0.84%)
DOW   32,417.81 (+0.54%)
QQQ   308.35 (+0.78%)
AAPL   158.58 (+0.75%)
MSFT   272.72 (+0.18%)
META   200.08 (+1.15%)
GOOGL   104.55 (+3.29%)
AMZN   99.52 (+1.85%)
TSLA   196.10 (+7.01%)
NVDA   259.30 (+0.12%)
NIO   9.23 (+5.49%)
BABA   83.37 (+2.93%)
AMD   95.11 (-1.76%)
T   18.46 (-0.16%)
F   11.75 (+5.10%)
MU   58.26 (+1.08%)
CGC   1.98 (+6.45%)
GE   92.54 (+2.91%)
DIS   96.25 (+2.15%)
AMC   4.40 (+3.04%)
PFE   40.42 (-0.96%)
PYPL   75.84 (+3.59%)
NFLX   305.24 (+0.04%)
S&P 500   3,984.88 (+0.84%)
DOW   32,417.81 (+0.54%)
QQQ   308.35 (+0.78%)
AAPL   158.58 (+0.75%)
MSFT   272.72 (+0.18%)
META   200.08 (+1.15%)
GOOGL   104.55 (+3.29%)
AMZN   99.52 (+1.85%)
TSLA   196.10 (+7.01%)
NVDA   259.30 (+0.12%)
NIO   9.23 (+5.49%)
BABA   83.37 (+2.93%)
AMD   95.11 (-1.76%)
T   18.46 (-0.16%)
F   11.75 (+5.10%)
MU   58.26 (+1.08%)
CGC   1.98 (+6.45%)
GE   92.54 (+2.91%)
DIS   96.25 (+2.15%)
AMC   4.40 (+3.04%)
PFE   40.42 (-0.96%)
PYPL   75.84 (+3.59%)
NFLX   305.24 (+0.04%)
NASDAQ:TRVI

Trevi Therapeutics - TRVI News Today

$1.87
+0.07 (+3.89%)
(As of 03/21/2023 12:59 PM ET)
Add
Compare
Today's Range
$1.81
▼
$1.90
50-Day Range
$1.69
▼
$2.97
52-Week Range
$1.43
▼
$4.68
Volume
10,613 shs
Average Volume
54,189 shs
Market Capitalization
$112.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Get Trevi Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRVI and its competitors with MarketBeat's FREE daily newsletter.


TRVI Media Mentions By Week

TRVI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TRVI
News Sentiment
▼
0.47

0.35
▲
Average
Medical
News Sentiment

TRVI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TRVI Articles
This Week
▼
19

1
▲
TRVI Articles
Average Week

SourceHeadline
marketbeat.com logoOppenheimer Weighs in on Trevi Therapeutics, Inc.'s FY2027 Earnings (NASDAQ:TRVI)
marketbeat.com - March 20 at 2:43 AM
marketbeat.com logoTrevi Therapeutics (NASDAQ:TRVI) Earns "Buy" Rating from Needham & Company LLC
marketbeat.com - March 17 at 8:11 AM
MarketBeat logoTrevi Therapeutics (NASDAQ:TRVI) Earns Buy Rating from Needham & Company LLC
americanbankingnews.com - March 20 at 3:14 AM
finance.yahoo.com logoTrevi Therapeutics, Inc. (NASDAQ:TRVI) Q4 2022 Earnings Call Transcript
finance.yahoo.com - March 18 at 9:12 AM
markets.businessinsider.com logoTrevi Therapeutics (TRVI) Initiated with a Buy at JonesTrading
markets.businessinsider.com - March 17 at 1:21 PM
finanznachrichten.de logoTrevi Therapeutics, Inc.: Trevi Therapeutics Announces Fourth Quarter and Year End 2022 Financial Results and Provides Business Update
finanznachrichten.de - March 17 at 7:39 AM
finance.yahoo.com logoQ4 2022 Trevi Therapeutics Inc Earnings Call
finance.yahoo.com - March 17 at 7:39 AM
msn.com logoTrevi Therapeutics GAAP EPS of -$0.06 beats by $0.03
msn.com - March 16 at 8:37 PM
finance.yahoo.com logoTrevi Therapeutics Announces Fourth Quarter and Year End 2022 Financial Results and Provides Business Update
finance.yahoo.com - March 16 at 8:37 PM
benzinga.com logoTrevi Therapeutics Stock (NASDAQ:TRVI), Short Interest Report
benzinga.com - March 16 at 1:16 AM
msn.com logoEarnings Outlook For Trevi Therapeutics
msn.com - March 15 at 3:15 PM
MarketBeat logoTrevi Therapeutics (NASDAQ:TRVI) Research Coverage Started at Jonestrading
americanbankingnews.com - March 15 at 8:22 AM
MarketBeat logoTrevi Therapeutics (TRVI) Scheduled to Post Quarterly Earnings on Thursday
americanbankingnews.com - March 15 at 1:54 AM
MarketBeat logoTrevi Therapeutics, Inc. (NASDAQ:TRVI) Sees Large Decline in Short Interest
americanbankingnews.com - March 14 at 7:24 AM
finance.yahoo.com logoTrevi Therapeutics to Report Q4 and Year End 2022 Financial Results and Provide a Corporate Update on March 16, 2023
finance.yahoo.com - March 9 at 5:56 PM
finance.yahoo.com logoTrevi Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering Use of Haduvio™ (nalbuphine ER) for the Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis
finance.yahoo.com - March 8 at 11:20 AM
finance.yahoo.com logoTrevi Therapeutics to Participate in Upcoming March Conferences
finance.yahoo.com - March 6 at 5:22 PM
finance.yahoo.com logoTrevi Therapeutics to Present at the Emerging Growth Conference on February 22, 2023
finance.yahoo.com - February 16 at 9:51 AM
finance.yahoo.com logoTrevi Therapeutics to Present and Participate in Upcoming February Conferences
finance.yahoo.com - February 2 at 7:35 AM
finance.yahoo.com logoTrevi Therapeutics, Inc. Discusses Progress and 2022 Success of Clinical Studies for Its Investigational Oral Therapy Haduvio(TM) with The Stock Day Podcast
finance.yahoo.com - January 25 at 12:26 PM
finance.yahoo.com logoTrevi Therapeutics Provides Business Update Ahead of Upcoming Conferences
finance.yahoo.com - January 5 at 7:32 PM
finance.yahoo.com logoTrevi Therapeutics, Inc.'s (NASDAQ:TRVI) stock price dropped 13% last week; private equity firms would not be happy
finance.yahoo.com - December 26 at 12:46 PM
seekingalpha.com logoTRVI Trevi Therapeutics, Inc.
seekingalpha.com - December 23 at 7:12 PM
finance.yahoo.com logoTrevi Therapeutics to Present and Participate in Upcoming Conferences in San Francisco During the 41st Annual J.P. Morgan Health Care Conference
finance.yahoo.com - December 19 at 5:46 PM
finance.yahoo.com logoTrevi Therapeutics Appoints Pharma Industry Veteran as Chief Medical Officer
finance.yahoo.com - November 14 at 4:47 PM
seekingalpha.com logoTrevi Therapeutics, Inc. (TRVI) Q3 2022 Earnings Call Transcript
seekingalpha.com - November 13 at 10:52 PM
finance.yahoo.com logoTrevi Therapeutics Announces Third Quarter 2022 Financial Results and Provides Business Update
finance.yahoo.com - November 10 at 8:30 PM
benzinga.com logoEarnings Outlook For Trevi Therapeutics, Inc. - Common Stock
benzinga.com - November 9 at 1:56 PM
finance.yahoo.com logoTrevi Therapeutics to Participate at the Stifel 2022 Healthcare Conference
finance.yahoo.com - November 8 at 9:18 AM
finance.yahoo.com logoTrevi Therapeutics to Report Q3 2022 Financial Results and Provide a Corporate Update on November 10, 2022
finance.yahoo.com - November 4 at 10:20 AM
finance.yahoo.com logoTrevi Therapeutics to Present Final Data from Phase 2 Trial of Oral Nalbuphine Extended Release for Chronic Cough in IPF at BTS' Winter Meeting
finance.yahoo.com - October 27 at 6:54 PM
au.investing.com logoAfter-Hours Movers: Spectrum Pharm Sinks on Negative FDA Panel, Costco Dips on...
au.investing.com - September 23 at 7:44 AM
finance.yahoo.com logo/C O R R E C T I O N -- Trevi Therapeutics, Inc./
finance.yahoo.com - September 23 at 7:44 AM
finance.yahoo.com logoTrevi Therapeutics Announces Proposed Public Offering
finance.yahoo.com - September 23 at 12:59 AM
finance.yahoo.com logoTrevi Therapeutics Shares Jump After Complete Data From Chronic Cough Trial
finance.yahoo.com - September 19 at 4:58 PM
markets.businessinsider.com logoTrevi Reports Positive Results From Full Set Of Subjects From CANAL Trial Of Haduvio
markets.businessinsider.com - September 19 at 11:58 AM
finance.yahoo.com logoTrevi Therapeutics Announces Positive Data from Full Set of Subjects in Phase 2 CANAL Trial of Haduvio™ in the Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis
finance.yahoo.com - September 19 at 11:58 AM
finance.yahoo.com logoIs AVEO Pharmaceuticals (AVEO) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - September 14 at 11:20 AM
seekingalpha.com logoTrevi Therapeutics: Moving Forward
seekingalpha.com - September 11 at 3:58 PM
finance.yahoo.com logoTrevi Therapeutics to Host Virtual R&D Day on September 19, 2022
finance.yahoo.com - August 30 at 5:45 PM
nasdaq.com logoWhat Type Of Shareholders Own The Most Number of Trevi Therapeutics, Inc. (NASDAQ:TRVI) Shares?
nasdaq.com - August 16 at 2:12 PM
finance.yahoo.com logoTrevi Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
finance.yahoo.com - August 11 at 4:49 PM
msn.com logoGloria Trevi On the Highs and Lows of Her 40-Year Career — And What Has Remained Consistent In Her Music
msn.com - August 8 at 5:35 PM
finance.yahoo.com logoTrevi Therapeutics to Report Q2 2022 Financial Results and Provide a Corporate Update on August 11, 2022
finance.yahoo.com - August 4 at 7:12 PM
finance.yahoo.com logoIs Trevi Therapeutics, Inc.'s (NASDAQ:TRVI) Shareholder Ownership Skewed Towards Insiders?
finance.yahoo.com - July 19 at 2:22 PM
finance.yahoo.com logoTraders News Source Senior Editor Mark Roberts Interviews Jennifer Good CEO of Trevi Therapeutics
finance.yahoo.com - July 14 at 9:39 AM
uk.finance.yahoo.com logoWhich way is the Trevi Therapeutics share price trending?
uk.finance.yahoo.com - July 6 at 5:41 PM
finance.yahoo.com logoWhy Did Needham Lift Price Target For Trevi?
finance.yahoo.com - June 30 at 6:44 PM
stocknews.com logoWall Street Predicts These 2 Sub-$5 Stocks Have More Than 200% Upside
stocknews.com - June 30 at 1:12 PM
finance.yahoo.com logoWhy Trevi Therapeutics Shares Trading Higher Today?
finance.yahoo.com - June 29 at 5:53 PM
investorplace.com logoTrevi Therapeutics (TRVI) Stock Spikes 20% on Positive Clinical Data
investorplace.com - June 29 at 2:06 PM
investorplace.com logoTrevi Therapeutics (TRVI) Spikes 20% on Positive Clinical Data
investorplace.com - June 29 at 11:00 AM
Get Trevi Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRVI and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:TRVI) was last updated on 3/21/2023 by MarketBeat.com Staff